Home > Healthcare > Healthcare IT > Healthcare Outsourcing > Infection Control Surveillance Solutions Market

Infection Control Surveillance Solutions Market Size

Report ID: GMI5312
Published Date: Aug 2022
Report Format: PDF

Download Free Sample

Infection Control Surveillance Solutions Market Size

Infection Control Surveillance Solutions Market size surpassed USD 580 million in 2021 and is projected to expand at a CAGR of over 13% between 2022 and 2030. The prevalence of nosocomial infections will spur the global industry growth.

To get key market trends

Download Free Sample

The increasing prevalence of nosocomial infections is among the primary factors supporting the industry expansion during the forecast period. Nosocomial infections or Healthcare-associated infections (HAI) are acquired due to prolonged stay or while undergoing treatment across hospital settings. They usually occur within 48 hours or 30 days post-discharge and may include urinary tract infections, surgical site wound infections, respiratory pneumonia, bacteremia, and gastrointestinal and skin infections, among others.

Infection Control Surveillance Solutions Market Report Attributes
Report Attribute	Details
Base Year:	2021
Infection Control Surveillance Solutions Market Size in 2021:	USD 582.4 Million
Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	13.4%
2030 Value Projection:	USD 1,797.7 Million
Historical Data for:	2017 to 2021
No. of Pages:	240
Tables, Charts & Figures:	182
Segments covered:	Component, End-use, and Region
Growth Drivers:	Surge in the number of nosocomial infections Rising technological advancements in the healthcare IT infrastructure Growing prevalence of infectious and chronic diseases
Pitfalls & Challenges:	Unwillingness among healthcare professionals to adopt innovative healthcare IT solutions Improper data management and lack of knowledge regarding IT among healthcare professionals

Learn more about the key segments shaping this market

Download Free Sample

According to the Center for Disease Control and Prevention estimations under the National Healthcare Safety Network (NHSN), urinary tract infections (UTIs) are the most common and widespread hospital-associated infections. In addition, the rapid growth of the aging population and their susceptibility to such infections are likely to create new growth prospects for the infection control surveillance solutions industry in the forthcoming years.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for infection control surveillance solutions exceeded USD 580 million in 2021 and is anticipated to expand at a CAGR of over 13% between 2022 and 2030 due to increasing incidences of nosocomial infections.

North America infection control surveillance solutions industry constituted over 44% of the market share in 2021 and is likely to witness further progression due to increasing health concerns and rising healthcare expenditure.

The hospital segment held for more than 67% of the industry share in 2021 and is speculated to register significant expansion during the assessment period due to expanding healthcare infrastructure and the construction of new facilities.

Some prominent companies in the infection control surveillance solutions industry are Baxter International Inc., Premier, Inc., Cerner Corporation, Becton, Dickinson, and Company, GOJO Industries, Inc., Sunquest, IBM Corporation, OASIS Medical, and others